Clinical Trial

Novel Strategies for Reducing Burn Scar Itch

Recruiting Phase 3
View on ClinicalTrials.gov →
Summary
The purpose of the study is to see whether using diphenhydramine (Benadryl), famotidine (Pepcid), and cromolyn sodium will decrease burn scar itch.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2025-01-24; most recent amendment 2025-09-18.
Status change: Not Yet Recruiting → Recruiting 2025-05-01
Trial Details
NCT Number NCT06801626
Lead Sponsor The University of Texas Medical Branch, Galveston
Collaborators: University of Texas
Conditions Burn Scar, Itch Scarring, Wound
Enrollment 44 participants
Start Date 2025-03-01
Primary Completion 2026-12-31 (estimated)
Study Completion 2027-11-01 (estimated)
Updated on ClinicalTrials.gov 2025-09-24